Raras
Buscar doenças, sintomas, genes...
Síndrome Cushing dependente de ACTH
ORPHA:99892CID-10 · E24.0DOENÇA RARA

São casos da Síndrome de Cushing que se desenvolvem no próprio corpo (endógena), causados por uma produção anormal e excessiva do hormônio ACTH. Essa produção extra pode vir de um tumor na glândula hipófise (geralmente benigno, chamado adenoma) ou de um tumor localizado em outra parte do corpo, fora da hipófise.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

São casos da Síndrome de Cushing que se desenvolvem no próprio corpo (endógena), causados por uma produção anormal e excessiva do hormônio ACTH. Essa produção extra pode vir de um tumor na glândula hipófise (geralmente benigno, chamado adenoma) ou de um tumor localizado em outra parte do corpo, fora da hipófise.

Pesquisas ativas
2 ensaios
2 total registrados no ClinicalTrials.gov
Publicações científicas
80 artigos
Último publicado: 2026 Apr 7

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E24.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
13 sintomas
🧠
Neurológico
10 sintomas
🧬
Pele e cabelo
7 sintomas
🫃
Digestivo
5 sintomas
🩸
Sangue
5 sintomas
🫁
Pulmão
4 sintomas

+ 41 sintomas em outras categorias

Características mais comuns

Hiperplasia adrenal
Livedo reticularis
Compressão do nervo óptico
Necrose avascular
Defeito do campo visual
Cefaleia
102sintomas
Sem dados (102)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 102 características clínicas mais associadas, ordenadas por frequência.

Hiperplasia adrenalAdrenal hyperplasia
Livedo reticularis
Compressão do nervo ópticoOptic nerve compression
Necrose avascularAvascular necrosis
Defeito do campo visualVisual field defect

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico80PubMed
Últimos 10 anos63publicações
Pico202513 papers
Linha do tempo
2026Hoje · 2026🧪 2015Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

7 genes identificados com associação a esta condição.

USP8Ubiquitin carboxyl-terminal hydrolase 8Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates t

LOCALIZAÇÃO

CytoplasmNucleusEndosome membraneCell membrane

VIAS BIOLÓGICAS (4)
Downregulation of ERBB2:ERBB3 signalingRegulation of FZD by ubiquitinationNegative regulation of MET activityUb-specific processing proteases
MECANISMO DE DOENÇA

Pituitary adenoma 4, ACTH-secreting

A form of pituitary adenoma, a neoplasm of the pituitary gland and one of the most common neuroendocrine tumors. Pituitary adenomas are clinically classified as functional and non-functional tumors, and manifest with a variety of features, including local invasion of surrounding structures and excessive hormone secretion. Functional pituitary adenomas are further classified by the type of hormone they secrete. PITA4 results in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.4 TPM
Linfócitos
9.2 TPM
Nervo tibial
9.1 TPM
Cervix Endocervix
8.7 TPM
Ovário
8.3 TPM
OUTRAS DOENÇAS (2)
Cushing disease due to pituitary adenomaautosomal recessive spastic paraplegia type 59
HGNC:12631UniProt:P40818
CDH23Cadherin-23Candidate gene tested inTolerante
FUNÇÃO

Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells. CDH23 is required for establishing and/or maintaining the proper organization of the stereocilia bundle of hair cells in the cochlea and the vestibule during late embryonic/early postnatal development. It is part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for norma

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1D

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

OUTRAS DOENÇAS (12)
autosomal recessive nonsyndromic hearing loss 12Usher syndrome type 1Dnonsyndromic genetic hearing lossUsher syndrome
HGNC:13733UniProt:Q9H251
USP48Ubiquitin carboxyl-terminal hydrolase 48Candidate gene tested inAltamente restrito
FUNÇÃO

Deubiquitinase that recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of polyubiquitin precursors as well as that of ubiquitinated proteins (PubMed:16214042, PubMed:34059922). Plays a role in the regulation of NF-kappa-B activation by TNF receptor superfamily via its interactions with RELA and TRAF2. May also play a regulatory role at postsynaptic sites. Plays an important role in cell cycle progression by deubiquitinating Aurora B/AURKB an

LOCALIZAÇÃO

CytoplasmNucleusCell projection, cilium

VIAS BIOLÓGICAS (1)
Ub-specific processing proteases
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 85

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA85 is characterized by progressive hearing loss, with onset in childhood or young adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
68.8 TPM
Cérebro - Hemisfério cerebelar
55.8 TPM
Cerebelo
55.3 TPM
Ovário
36.8 TPM
Glândula adrenal
35.5 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 85autosomal dominant nonsyndromic hearing lossCushing disease due to pituitary adenoma
HGNC:18533UniProt:Q86UV5
BRAFSerine/threonine-protein kinase B-rafCandidate gene tested inAltamente restrito
FUNÇÃO

Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus (Probable). Phosphorylates MAP2K1, and thereby activates the MAP kinase signal transduction pathway (PubMed:21441910, PubMed:29433126). Phosphorylates PFKFB2 (PubMed:36402789). May play a role in the postsynaptic responses of hippocampal neurons (PubMed:1508179)

LOCALIZAÇÃO

NucleusCytoplasmCell membrane

VIAS BIOLÓGICAS (4)
Spry regulation of FGF signalingParadoxical activation of RAF signaling by kinase inactive BRAFARMS-mediated activationSignalling to p38 via RIT and RIN
OUTRAS DOENÇAS (18)
Noonan syndrome 7LEOPARD syndrome 3melanoma, cutaneous malignant, susceptibility to, 1lung cancer
HGNC:1097UniProt:P15056
NR3C1Glucocorticoid receptorCandidate gene tested inAltamente restrito
FUNÇÃO

Receptor for glucocorticoids (GC) (PubMed:27120390, PubMed:37478846). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors (PubMed:28139699). Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of ta

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeChromosomeNucleus, nucleoplasm

VIAS BIOLÓGICAS (6)
PTK6 ExpressionRegulation of RUNX2 expression and activityRegulation of NPAS4 gene transcriptionFOXO-mediated transcription of oxidative stress, metabolic and neuronal genesSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

Glucocorticoid resistance, generalized

An autosomal dominant disease characterized by increased plasma cortisol concentration and high urinary free cortisol, resistance to adrenal suppression by dexamethasone, and the absence of Cushing syndrome typical signs. Clinical features include hypoglycemia, hypertension, metabolic alkalosis, chronic fatigue and profound anxiety.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
55.3 TPM
Nervo tibial
34.5 TPM
Tecido adiposo
34.1 TPM
Fibroblastos
33.6 TPM
Artéria tibial
32.7 TPM
OUTRAS DOENÇAS (2)
glucocorticoid resistanceCushing disease due to pituitary adenoma
HGNC:7978UniProt:P04150
TP53Cellular tumor antigen p53Candidate gene tested inAltamente restrito
FUNÇÃO

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed:11025664, PubMed:12524540, PubMed:12810724, PubMed:15186775, PubMed:15340061, PubMed:17317671, PubMed:17349958, PubMed:19556538, PubMed:20673990, PubMed:20959462, PubMed:22726440, PubMed:24051492, PubMed:24652652, PubMed:35618207, PubMed:36634798, PubMed:38653238, PubMed:9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apop

LOCALIZAÇÃO

CytoplasmNucleusNucleus, PML bodyEndoplasmic reticulumMitochondrion matrixCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (10)
TP53 Regulates Metabolic GenesRegulation of TP53 ExpressionRegulation of TP53 DegradationOncogene Induced SenescenceOxidative Stress Induced Senescence
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
73.0 TPM
Skin Sun Exposed Lower leg
37.0 TPM
Skin Not Sun Exposed Suprapubic
35.2 TPM
Fibroblastos
32.9 TPM
Ovário
32.4 TPM
OUTRAS DOENÇAS (29)
Li-Fraumeni syndromenasopharyngeal carcinoma, susceptibility to, 1hepatocellular carcinomafamilial pancreatic carcinoma
HGNC:11998UniProt:P04637
ATRXTranscriptional regulator ATRXCandidate gene tested inAltamente restrito
FUNÇÃO

Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling

LOCALIZAÇÃO

NucleusChromosome, telomereNucleus, PML body

VIAS BIOLÓGICAS (2)
Inhibition of DNA recombination at telomereDefective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations
MECANISMO DE DOENÇA

Alpha-thalassemia/impaired intellectual development syndrome, X-linked

A disorder characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions.

OUTRAS DOENÇAS (5)
intellectual disability-hypotonic facies syndrome, X-linked, 1alpha-thalassemia-myelodysplastic syndromealpha thalassemia-X-linked intellectual disability syndromegastric neuroendocrine neoplasm
HGNC:886UniProt:P46100

Variantes genéticas (ClinVar)

1,346 variantes patogênicas registradas no ClinVar.

🧬 USP8: NM_005154.5(USP8):c.*1188C>A ()
🧬 USP8: NM_005154.5(USP8):c.1104A>G (p.Gln368=) ()
🧬 USP8: NM_005154.5(USP8):c.686+156T>G ()
🧬 USP8: NM_005154.5(USP8):c.541+81A>G ()
🧬 USP8: GRCh37/hg19 15q21.1-21.2(chr15:47392800-52877953)x1 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

62 vias biológicas associadas aos genes desta condição.

Downregulation of ERBB2:ERBB3 signaling Regulation of FZD by ubiquitination Ub-specific processing proteases Negative regulation of MET activity Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea Spry regulation of FGF signaling Frs2-mediated activation ARMS-mediated activation Signalling to p38 via RIT and RIN RAF activation MAP2K and MAPK activation Negative feedback regulation of MAPK pathway Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants SHOC2 M1731 mutant abolishes MRAS complex function Gain-of-function MRAS complexes activate RAF signaling HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Nuclear Receptor transcription pathway SUMOylation of intracellular receptors PTK6 Expression Regulation of RUNX2 expression and activity FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes Potential therapeutics for SARS Regulation of NPAS4 gene transcription Activation of NOXA and translocation to mitochondria Activation of PUMA and translocation to mitochondria Pre-NOTCH Transcription and Translation Oxidative Stress Induced Senescence Formation of Senescence-Associated Heterochromatin Foci (SAHF) Oncogene Induced Senescence DNA Damage/Telomere Stress Induced Senescence SUMOylation of transcription factors Autodegradation of the E3 ubiquitin ligase COP1 Association of TriC/CCT with target proteins during biosynthesis Pyroptosis TP53 Regulates Metabolic Genes Ovarian tumor domain proteases Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Interleukin-4 and Interleukin-13 signaling TP53 Regulates Transcription of DNA Repair Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain TP53 Regulates Transcription of Caspase Activators and Caspases TP53 Regulates Transcription of Death Receptors and Ligands TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest Regulation of TP53 Expression Regulation of TP53 Activity through Phosphorylation Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors Regulation of TP53 Activity through Methylation Inhibition of DNA recombination at telomere Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Cushing dependente de ACTH

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
64 papers (10 anos)
#1

Safety and Effectiveness of Rivaroxaban Thromboprophylaxis in ACTH-dependent Cushing Syndrome.

The Journal of clinical endocrinology and metabolism2026 Jan 16

Pacientes com Síndrome de Cushing ACTH-dependente enfrentam um alto risco de trombose venosa (VTE). Este estudo demonstrou que a profilaxia rotineira com rivaroxabana oral (10 mg/dia) foi extremamente eficaz, eliminando eventos de VTE após sua introdução (comparado a 13,8% sem profilaxia), e segura, sem sangramentos. Para pacientes e médicos, isso sugere a importância de iniciar precocemente a rivaroxabana ao diagnóstico e mantê-la nos períodos peri e pós-operatório para prevenir coágulos.

🇧🇷 traduzido
#2

18 F-FDG PET/CT and 68 Ga-DOTA-NOC PET/MRI in an Adolescent With Ectopic Adrenocorticotropic Hormone Syndrome From a Presacral Teratoma.

Clinical nuclear medicine2026 Mar 01

Este artigo descreve o caso de uma adolescente com Síndrome de Cushing grave causada por um tumor raro (um teratoma contendo um NET secretor de ACTH) localizado no sacro. O diagnóstico preciso dessa fonte ectópica de ACTH exigiu a combinação de exames de imagem avançados, como PET/CT e PET/MRI, que foram cruciais para localizar e caracterizar o tumor. Para pacientes e médicos, este caso enfatiza a necessidade de investigação diagnóstica aprofundada e o uso de múltiplas modalidades de imagem em crianças com Cushing grave, a fim de identificar a fonte funcional do problema e guiar o tratamento adequado.

🇧🇷 traduzido
#3

Overnight Dexamethasone Suppression Test: Enhanced Accuracy With Late-afternoon Cortisol and Morning/Late-afternoon ACTH.

The Journal of clinical endocrinology and metabolism2026 Feb 20

O teste de supressão com dexametasona noturna (ODST) para diagnosticar a Síndrome de Cushing ACTH-dependente, embora sensível, pode ter especificidade limitada. Este estudo demonstra que a medição do cortisol no final da tarde e do ACTH na manhã e no final da tarde, após a dexametasona, pode aumentar significativamente a precisão do teste. A medição do ACTH mostrou-se especialmente útil em pacientes que usam contraceptivos orais ou têm doença renal crônica, atingindo 100% de sensibilidade para o diagnóstico, enquanto o cortisol do final da tarde aprimorou a distinção entre remissão e persistência da doença. Embora promissoras, essas modificações inovadoras requerem validação adicional antes de serem amplamente adotadas na prática clínica.

🇧🇷 traduzido
#4

Challenges in diagnosis and treatment of cushing disease in a 12-year-old boy. Case report.

La Pediatria medica e chirurgica : Medical and surgical pediatrics2025 Feb 11

Este caso de um menino de 12 anos destaca a raridade e os desafios no diagnóstico da Doença de Cushing na pediatria, onde exames de imagem frequentemente falham em identificar o microadenoma produtor de ACTH. Para pacientes e médicos, é crucial saber que o diagnóstico definitivo muitas vezes requer testes especializados como a coleta de amostras do seio petroso inferior (IPSS). O tratamento bem-sucedido, que incluiu cirurgia e radioterapia, normalizou o hipercortisolismo, mas resultou em uma complicação relevante: a deficiência de hormônio do crescimento, exigindo acompanhamento futuro.

🇧🇷 traduzido
#5

Ectopic Adrenocorticotropic Hormone (ACTH)-Dependent Cushing Syndrome Secondary to Olfactory Neuroblastoma: A Rare Entity.

AACE endocrinology and diabetes2025

Este artigo descreve um caso extremamente raro de Síndrome de Cushing dependente de ACTH, causada por um neuroblastoma olfativo (ONB) – um tipo de tumor nasal que secreta ACTH. Para pacientes e médicos, o caso enfatiza a importância de um diagnóstico sistemático e multidisciplinar para identificar a fonte rara de ACTH, e que a remoção cirúrgica completa do tumor, com terapia adjuvante, pode levar à remissão total da doença e melhora significativa.

🇧🇷 traduzido

Publicações recentes

Ver todas no PubMed

📚 EuropePMC30 artigos no totalmostrando 62

2026

Safety and Effectiveness of Rivaroxaban Thromboprophylaxis in ACTH-dependent Cushing Syndrome.

The Journal of clinical endocrinology and metabolism
2025

Ectopic Adrenocorticotropic Hormone (ACTH)-Dependent Cushing Syndrome Secondary to Olfactory Neuroblastoma: A Rare Entity.

AACE endocrinology and diabetes
2026

18 F-FDG PET/CT and 68 Ga-DOTA-NOC PET/MRI in an Adolescent With Ectopic Adrenocorticotropic Hormone Syndrome From a Presacral Teratoma.

Clinical nuclear medicine
2025

A comparison of bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling at Mayo Clinic for the subtype evaluation of corticotropin-dependent cushing syndrome.

Pituitary
2026

Overnight Dexamethasone Suppression Test: Enhanced Accuracy With Late-afternoon Cortisol and Morning/Late-afternoon ACTH.

The Journal of clinical endocrinology and metabolism
2025

Rapid Adrenal Atrophy Following Excision of an Ectopic Adrenocorticotropin-Secreting Lung Carcinoid Tumor.

JCEM case reports
2025

Prolactin-adjusted inferior petrosal sinus sampling: Pituitary and ectopic adrenocorticotropic hormone-dependent Cushing syndrome.

Journal of neuroendocrinology
2025

Radiofrequency Ablation: Alternative Treatment of Ectopic Adrenocorticotropic Syndrome Secondary to Lung Carcinoid Tumor.

JCEM case reports
2025

A Second Look at Cushing Disease: Hypercortisolism Recurrence From Another Gland.

JCEM case reports
2025

ACTH-dependent Cyclic Cushing Syndrome With Successful Pregnancy and Early Postpartum Relapse.

JCEM case reports
2025

Challenges in diagnosis and treatment of cushing disease in a 12-year-old boy. Case report.

La Pediatria medica e chirurgica : Medical and surgical pediatrics
2024

Posterior Reversible Encephalopathy Syndrome in the Context of McCune-Albright Syndrome: A Case Report.

Cureus
2025

Successful Treatment of Severe Ectopic ACTH-Dependent Cushing Syndrome Complicated by Hypocalcemia With Osilodrostat.

JCEM case reports
2024

Complete Tumor Resection and Radical Lymphadenectomy: Potential Cure for Adrenocorticotropic Hormone (ACTH)-Dependent Pulmonary Carcinoid.

Cureus
2025

Longitudinal Evaluation of Reproductive Endocrine Function in Men With ACTH-Dependent Cushing Syndrome.

The Journal of clinical endocrinology and metabolism
2024

ACTH-dependent Cushing Syndrome with No Peripheral Response But a Marked Petrosal Sinus ACTH Response to Desmopressin.

JCEM case reports
2024

The diagnostic yield of inferior petrosal sinus sampling in Cushing syndrome in the era of ovine CRH shortage.

Acta neurochirurgica
2025

Machine Learning May Be an Alternative to BIPSS in the Differential Diagnosis of ACTH-dependent Cushing Syndrome.

The Journal of clinical endocrinology and metabolism
2024

Delayed Diagnosis of Ectopic Cushing Syndrome.

JCEM case reports
2024

A Case of an Ectopic ACTH-Producing Tumor With Adrenal Shrinkage During Osilodrostat Administration.

JCEM case reports
2024

Utility of Simple and Non-Invasive Strategies Alternative to Inferior Petrosal Sinus Sampling and Peripheral CRH Stimulation in Differential Diagnosis of ACTH-Dependent Cushing Syndrome.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
2025

False-Negative Inferior Petrosal Sinus Sampling in Young-Onset Cushing Disease: What Happens Next.

Hormone research in paediatrics
2023

Adrenocorticotropic Hormone-Dependent Cushing's Syndrome Complicated With Gastric Ulcer Perforation in a 30-Year-Old Saudi Female: A Case Report and a Review of the Literature.

Cureus
2024

Alternative Approach to BIPSS in the Differential Diagnosis of ACTH-Dependent Cushing Syndrome.

The Journal of clinical endocrinology and metabolism
2023

Clival Ectopic Pituitary Adenoma Causing Cushing Syndrome.

JCEM case reports
2023

Heterogeneity of TPIT expression in ACTH-secreting extra-pituitary neuroendocrine tumors (NETs) supports the existence of different cellular programs in pancreatic and pulmonary NETs.

Virchows Archiv : an international journal of pathology
2023

ACTH-Secreting Renal Neuroendocrine Tumor on 68 Ga-DOTATATE PET/CT.

Clinical nuclear medicine
2023

A case report and literature review of Carney complex with atrial adenomyxoma.

BMC endocrine disorders
2023

Should We Use Prolactin Adjustment in Bilateral Inferior Petrosal Sinus Sampling to Diagnose Cushing Disease? A Joint Meta-Analysis of Head-to-Head Diagnostic Tests Accuracy Studies.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2022

Corticotroph cell hyperplasia as a rare cause of ACTH-dependent Cushing syndrome.

Endocrinologia, diabetes y nutricion
2023

Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review and Meta-analysis.

The Journal of clinical endocrinology and metabolism
2022

Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.

BMC endocrine disorders
2022

Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.

European journal of endocrinology
2022

Rapidly Fatal Ectopic Adrenocorticotropic Hormone Syndrome in a 9-Year-Old Girl With Ewing Sarcoma.

AACE clinical case reports
2022

Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review.

International journal of surgery case reports
2021

Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome.

Journal of clinical &amp; translational endocrinology
2021

Etiology-, Sex-, and Tumor Size-Based Differences in Adrenocorticotropin-Dependent Cushing Syndrome.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2021

To determine the efficacy of bilateral inferior petrosal sinus sampling in differentiating Cushing disease from ectopic Cushing syndrome.

JPMA. The Journal of the Pakistan Medical Association
2021

Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review.

The Journal of clinical endocrinology and metabolism
2020

Percutaneous Bilateral Adrenal Radiofrequency Ablation in Severe Adrenocorticotropic Hormone-dependent Cushing Syndrome.

Journal of clinical imaging science
2020

Is it Time for a New Approach to the Differential Diagnosis of ACTH-Dependent Cushing Syndrome?

The Journal of clinical endocrinology and metabolism
2020

Differential diagnostic value of bilateral inferior Petrosal sinus sampling (BIPSS) in ACTH-dependent Cushing syndrome: a systematic review and Meta-analysis.

BMC endocrine disorders
2020

Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

Journal of the Endocrine Society
2021

Ectopic ACTH- and/or CRH-Producing Pheochromocytomas.

The Journal of clinical endocrinology and metabolism
2020

Bilateral Adrenalectomy: Differences between Cushing Disease and Ectopic ACTH-Producing Tumors.

Annals of surgical oncology
2019

Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?

Endocrinology, diabetes &amp; metabolism case reports
2019

68Ga-DOTATATE PET/CT of Ectopic Cushing Syndrome Due to Appendicular Carcinoid.

Clinical nuclear medicine
2019

Challenges in diagnosis of disease reported 100 years back: Cushing syndrome; recent advances.

JPMA. The Journal of the Pakistan Medical Association
2019

An Uncommon Case of Ectopic Adrenocorticotropic Hormone Syndrome from a Pancreatic Neuroendocrine Tumor.

Cureus
2019

Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.

Nuclear medicine communications
2019

Adrenocorticotropic Hormone-Dependent Cushing Syndrome Caused by an Olfactory Neuroblastoma.

Clinical medicine insights. Endocrinology and diabetes
2018

Severe Cushing Syndrome Due to an ACTH-Producing Pheochromocytoma: A Case Presentation and Review of the Literature.

Journal of the Endocrine Society
2018

Case-series of paraneoplastic Cushing syndrome in small-cell lung cancer.

Endocrinology, diabetes &amp; metabolism case reports
2017

Case report of a bilateral adrenal myelolipoma associated with Cushing disease.

Medicine
2017

Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination.

Melanoma research
2017

A Case of Pulmonary Carcinoid Tumor with a Superimposed Aspergilloma Presenting As a Covert Ectopic Adrenocorticotropic Hormone Syndrome.

Frontiers in endocrinology
2016

VENOUS SAMPLING FOR CUSHING DISEASE: COMPARISON OF INTERNAL JUGULAR VEIN AND INFERIOR PETROSAL SINUS SAMPLING.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2015

The first description of metyrapone use in severe Cushing Syndrome due to ectopic ACTH secretion in an infant with immature sacrococcygeal teratoma. Case Report.

Neuro endocrinology letters
2015

A Case of Ectopic Adrenocorticotropic Hormone Syndrome in Small Cell Lung Cancer.

Tuberculosis and respiratory diseases
2015

PITUITARY MRI FINDINGS IN PATIENTS WITH PITUITARY AND ECTOPIC ACTH-DEPENDENT CUSHING SYNDROME: DOES A 6-MM PITUITARY TUMOR SIZE CUT-OFF VALUE EXCLUDE ECTOPIC ACTH SYNDROME?

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2015

Cushing syndrome: update on testing.

Endocrinology and metabolism clinics of North America
2015

Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.

Neurosurgical focus

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Cushing dependente de ACTH.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Cushing dependente de ACTH

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Safety and Effectiveness of Rivaroxaban Thromboprophylaxis in ACTH-dependent Cushing Syndrome.
    The Journal of clinical endocrinology and metabolism· 2026· PMID 41540719mais citado
  2. 18 F-FDG PET/CT and 68 Ga-DOTA-NOC PET/MRI in an Adolescent With Ectopic Adrenocorticotropic Hormone Syndrome From a Presacral Teratoma.
    Clinical nuclear medicine· 2026· PMID 41400990mais citado
  3. Overnight Dexamethasone Suppression Test: Enhanced Accuracy With Late-afternoon Cortisol and Morning/Late-afternoon ACTH.
    The Journal of clinical endocrinology and metabolism· 2026· PMID 40972562mais citado
  4. Challenges in diagnosis and treatment of cushing disease in a 12-year-old boy. Case report.
    La Pediatria medica e chirurgica : Medical and surgical pediatrics· 2025· PMID 39932307mais citado
  5. Ectopic Adrenocorticotropic Hormone (ACTH)-Dependent Cushing Syndrome Secondary to Olfactory Neuroblastoma: A Rare Entity.
    AACE endocrinology and diabetes· 2025· PMID 41467146mais citado
  6. Ectopic ACTH-dependent Cushing syndrome due to mature ovarian teratoma.
    BMJ Case Rep· 2026· PMID 41946536recente
  7. A comparison of bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling at Mayo Clinic for the subtype evaluation of corticotropin-dependent cushing syndrome.
    Pituitary· 2025· PMID 41125990recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:99892(Orphanet)
  2. MONDO:0020528(MONDO)
  3. GARD:19699(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55789431(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Cushing dependente de ACTH
Compêndio · Raras BR

Síndrome Cushing dependente de ACTH

ORPHA:99892 · MONDO:0020528
Prevalência
Unknown
CID-10
E24.0 · Síndrome de Cushing dependente da hipófise
Ensaios
2 ativos
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0342442
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades